Navigation Links
Dynatronics Will Request Hearing with Nasdaq Regarding Listing Status
Date:11/8/2012

SALT LAKE CITY, Nov. 8, 2012 /PRNewswire/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced that on November 7, 2012, the Company received a Nasdaq Staff Determination Letter indicating that the Company has not complied with the $1.00 minimum bid rule for continued listing set forth in Listing Rule 5550(a)(2) and faces delisting from the Nasdaq Capital Market at the opening of business on November 16, 2012, unless the Company requests an appeal of the determination by the staff.

The Company will request an appeal of the delisting determination pursuant to procedures available under the Nasdaq Listing Rules.  The hearing panel is authorized to grant additional time to regain compliance, if the panel deems it appropriate. The Company's hearing request will stay the suspension of the Company's securities pending the hearing and a final determination by the panel. As part of its appeal, the Company will be required to provide the panel with a plan to regain compliance.  The Company's plan includes a commitment to effect a reverse stock split, if necessary.

"We have filed a definitive proxy statement requesting shareholder approval for a 1 for 5 reverse stock split to regain compliance," stated Kelvyn H. Cullimore, Jr., chairman and president of Dynatronics.  "With several positive developments taking place at the Company, including the recently announced introduction of our Dynatronics SolarisPlus product line and Quad7 products, we believe Dynatronics has a strong future and will be granted the time under our plan necessary to effect our reverse split in order to regain compliance with the rule."

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.


'/>"/>
SOURCE Dynatronics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics To Release Fiscal Third Quarter Results Tuesday, May 15, 2012; Conference Call set for 3:30 p.m. ET
2. Dynatronics Introduces New SolarisPlus Line of Therapy Products
3. Watson and Actavis Receive FTC Second Request
4. BHI Raises Awareness of Hearing Aids as Potential Therapy to Help Quiet "Ringing in the Ears" During National Tinnitus Awareness Week
5. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
6. Kill the Germs, Spare the Ears: Study Shows How to Create Effective Antibiotics That Dont Damage Hearing
7. United States ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
8. United Kingdom ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
9. China ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
10. India ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
11. Hearing Loss Could Lead to Multiple Chronic Diseases for Millions of Brits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... January 24, 2017 Analysis of the Liquid ... Liquid Biopsies - our new study reveals trends, R&D progress, ... If you are involved in this sector you must read this ... revenues streams to 2027, assessing data, trends, opportunities and business prospects ... Discover How ...
(Date:1/24/2017)... , and GAITHERSBURG, Md. , Jan. ... XON ), a leader in the engineering and industrialization of ... the planet, today announced that it has entered into a ... GNVC ), a clinical-stage company and pioneer in the ... intends to integrate and expand upon GenVec,s expertise in adenoviral ...
(Date:1/24/2017)... 2017   Keneric Healthcare , a medical ... patient care products, today announced their partnership with ... reach of both companies by leveraging their clinical ... Angelini Pharma Inc . is ... Keneric Healthcare,s RTD™ Wound Dressing (antibacterial/antifungal).  RTD™ wound ...
Breaking Medicine Technology:
(Date:1/24/2017)... Hills Estates, CA (PRWEB) , ... January 24, 2017 , ... ... performance at studies, work, athletics or even in relationships. Course offered by Dr. ... fee is necessary due to limited seating and the many hands-on experiences. ...
(Date:1/24/2017)... ... January 24, 2017 , ... West’s Health ... annual Solutions Series of webinars will start January 31 with a session about ... of current health and benefits topics, including employee engagement, pricing transparency, population health ...
(Date:1/24/2017)... TX (PRWEB) , ... January 24, 2017 , ... Bellus ... the company’s team of medical experts. In his new role Dr. Dobke will provide ... , Dr. Dobke is the Head of Plastic Surgery and Associate Professor of ...
(Date:1/24/2017)... Chapel Hill, N.C. (PRWEB) , ... January 24, ... ... the Trump Administration is the focus of a new report from the ... Carolina Kenan-Flagler Business School. , Influential business leaders, academics and policy makers identified ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... The results ... news for everyone and particularly good news for prostate cancer patients: incidents of cancer ... , According to the report the cancer death rate has dropped from its peak ...
Breaking Medicine News(10 mins):